New Jersey S 4601: Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

Status: Passed by the Senate (39-0) (as of 2026-10-22)

State: New Jersey · Session: 222 · Bill: S 4601

Sponsors: Vitale, Joseph F., Greenstein, Linda R., Mukherji, Raj

View New Jersey S 4601 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.